The H2S-generating enzyme 3-mercaptopyruvate sulfurtransferase regulates pulmonary vascular smooth muscle cell migration and proliferation but does not impact normal or aberrant lung development
Copyright © 2020 Elsevier Inc. All rights reserved..
Along with nitric oxide (NO), the gasotransmitters carbon monoxide (CO) and hydrogen sulfide (H2S) are emerging as potentially important players in newborn physiology, as mediators of newborn disease, and as new therapeutic modalities. Several recent studies have addressed H2S in particular in animal models of bronchopulmonary dysplasia (BPD), a common complication of preterm birth where oxygen toxicity stunts lung development. In those studies, exogenous H2S attenuated the impact of oxygen toxicity on lung development, and two H2S-generating enzymes were documented to affect pulmonary vascular development. H2S is directly generated endogenously by three enzymes, one of which, 3-mercaptopyruvate sulfurtransferase (MPST), has not been studied in the lung. In a hyperoxia-based animal model of BPD, oxygen exposure deregulated MPST expression during post-natal lung development, where MPST was localized to the smooth muscle layer of the pulmonary vessels in developing lungs. siRNA-mediated abrogation of MPST expression in human pulmonary artery smooth muscle cells in vitro limited baseline cell migration and cell proliferation, without affecting apoptosis or cell viability. In vivo, MPST was dispensable for normal lung development in Mpst-/-mice, and MPST did not contribute to stunted lung development driven by hyperoxia exposure, assessed by design-based stereology. These data demonstrate novel roles for MPST in pulmonary vascular smooth muscle cell physiology. The potential caveats of using Mpst-/- mice to study normal and aberrant lung development are also discussed, highlighting the possible confounding, compensatory effects of other H2S-generating enzymes that are present alongside MPST in the smooth muscle compartment of developing pulmonary vessels.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
|---|---|
| Enthalten in: |
Nitric oxide : biology and chemistry - 107(2021) vom: 01. Feb., Seite 31-45 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lignelli, Ettore [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.07.2021 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.niox.2020.12.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319035174 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319035174 | ||
| 003 | DE-627 | ||
| 005 | 20240229152440.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.niox.2020.12.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM319035174 | ||
| 035 | |a (NLM)33338600 | ||
| 035 | |a (PII)S1089-8603(20)30213-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lignelli, Ettore |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The H2S-generating enzyme 3-mercaptopyruvate sulfurtransferase regulates pulmonary vascular smooth muscle cell migration and proliferation but does not impact normal or aberrant lung development |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.07.2021 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
| 520 | |a Along with nitric oxide (NO), the gasotransmitters carbon monoxide (CO) and hydrogen sulfide (H2S) are emerging as potentially important players in newborn physiology, as mediators of newborn disease, and as new therapeutic modalities. Several recent studies have addressed H2S in particular in animal models of bronchopulmonary dysplasia (BPD), a common complication of preterm birth where oxygen toxicity stunts lung development. In those studies, exogenous H2S attenuated the impact of oxygen toxicity on lung development, and two H2S-generating enzymes were documented to affect pulmonary vascular development. H2S is directly generated endogenously by three enzymes, one of which, 3-mercaptopyruvate sulfurtransferase (MPST), has not been studied in the lung. In a hyperoxia-based animal model of BPD, oxygen exposure deregulated MPST expression during post-natal lung development, where MPST was localized to the smooth muscle layer of the pulmonary vessels in developing lungs. siRNA-mediated abrogation of MPST expression in human pulmonary artery smooth muscle cells in vitro limited baseline cell migration and cell proliferation, without affecting apoptosis or cell viability. In vivo, MPST was dispensable for normal lung development in Mpst-/-mice, and MPST did not contribute to stunted lung development driven by hyperoxia exposure, assessed by design-based stereology. These data demonstrate novel roles for MPST in pulmonary vascular smooth muscle cell physiology. The potential caveats of using Mpst-/- mice to study normal and aberrant lung development are also discussed, highlighting the possible confounding, compensatory effects of other H2S-generating enzymes that are present alongside MPST in the smooth muscle compartment of developing pulmonary vessels | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Gasotransmitter | |
| 650 | 4 | |a H(2)S | |
| 650 | 4 | |a Hydrogen sulfide | |
| 650 | 4 | |a Lung development | |
| 650 | 4 | |a MPST | |
| 650 | 4 | |a Smooth muscle | |
| 650 | 7 | |a Gasotransmitters |2 NLM | |
| 650 | 7 | |a Sulfurtransferases |2 NLM | |
| 650 | 7 | |a EC 2.8.1.- |2 NLM | |
| 650 | 7 | |a 3-mercaptopyruvate sulphurtransferase |2 NLM | |
| 650 | 7 | |a EC 2.8.1.2 |2 NLM | |
| 650 | 7 | |a Hydrogen Sulfide |2 NLM | |
| 650 | 7 | |a YY9FVM7NSN |2 NLM | |
| 700 | 1 | |a Palumbo, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Bayindir, Selahattin Görkem |e verfasserin |4 aut | |
| 700 | 1 | |a Nagahara, Noriyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Vadász, István |e verfasserin |4 aut | |
| 700 | 1 | |a Herold, Susanne |e verfasserin |4 aut | |
| 700 | 1 | |a Seeger, Werner |e verfasserin |4 aut | |
| 700 | 1 | |a Morty, Rory E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nitric oxide : biology and chemistry |d 1998 |g 107(2021) vom: 01. Feb., Seite 31-45 |w (DE-627)NLM093851162 |x 1089-8611 |7 nnns |
| 773 | 1 | 8 | |g volume:107 |g year:2021 |g day:01 |g month:02 |g pages:31-45 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.niox.2020.12.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 107 |j 2021 |b 01 |c 02 |h 31-45 | ||